Neglected tropical diseases

Neglected tropical diseases course now accessible via eLearning

03 August 2017 | Geneva –– The first free, on-line course on a neglected tropical disease is now available to the public.

The course on post-kala-azar dermal leishmaniasis (PKDL) aims to help health workers and field practitioners recognize this form of the disease which is often misdiagnosed. Anyone completing the course with a minimum score of 70% will be awarded a certificate.

Cameroon investigates yaws outbreak among indigenous populations

© Earnest Njih Tablah

21 July 2017 | Geneva –– The World Health Organization (WHO) is providing financial support, medicine, technical and logistical assistance to Cameroon to contain an outbreak of yaws among its tribal population in the country's east region.

Hundreds of people and household contacts have already been treated as medical teams continue to find cases in order to prevent the disease spreading to neighboring areas.

WHO responds to visceral leishmaniasis outbreak in Kenya

©Postigo Ruiz J./WHO. Child affected by kala-azar in Marsabit
county hospital, June 2017

26 June 2017 | Geneva | Nairobi ––The World Health Organization (WHO) has dispatched medical supplies to Kenya in response to an outbreak of visceral leishmaniasis in Marsabit County, with a population of over 290 000.

According to local media, four people have died as a result of this outbreak.

Eliminating sleeping sickness as a public health problem is on track

©Franco Minguell .J.R/WHO. Laboratory technicians performing
tests for sleeping sickness during a campaign in DRC

14 June 2017 | Geneva –– Uninterrupted control activities, improved surveillance and reinforced passive case-finding have resulted in the sustained decrease in new cases of human African trypanosomiasis (also known as sleeping sickness).

There were only 2184 new cases reported in 2016, as compared with fewer than 5000 in 2014 and 10000 in 2009.

Accelerating yaws eradication: antibiotic added to WHO’s essential medicines list


9 June 2017 | Geneva –– The World Health Organization (WHO) has indicated azithromycin as the antibiotic for the treatment of yaws - a chronic infectious disease that mainly affects children.

Its inclusion in WHO's latest Model list of Essential Medicines is expected to facilitate access to the medicine and enhance the implementation its eradication, worldwide.